The glucose response curve of an oral glucose tolerance test (OGTT) has been associated with insulin sensitivity. A monophasic curve has been shown to be more prevalent in hyperglycemic and T2D population. However, it is unknown whether shape of curve in a healthy normoglycemic population can be indicative of risk for developing T2D.

Purpose: We aimed to determine if glucose response morphology, monophasic (M) versus biphasic (B), may be indicative of glucose tolerance and a family history of T2D (FH).

Methods: Normoglycemic Mexican American Males (mean ± SEM; age 23.26 ± 0.66 years, BMI 25.69 ± 0.97 kg/m2) with (n=7) or without (n=7) a FH participated in this study. Body composition was measured by DXA, substrate utilization was measured by indirect calorimetry, maximal aerobic capacity (VO2max) was measured by a standardized graded exercise test. Participants consumed 75 g of glucose while fasting and blood glucose were assessed at 0, 30, 60, 90, and 120 min. Based on Tschritter et al. (2003) classification, glucose response curves were separated into M (n=10) and B (n=4) groups.

Results: There were no significant differences in body weight, BMI, fat mass, fat free mass, resting substrate utilization, VO2max and fasting blood glucose (BG) between groups (all P > 0.05). However, M were significantly glucose intolerant compared to B evident by a greater glucose area under the curve (M: 263.63 ± 11.34 AU; B: 209.20 ± 4.46 AU; p=0.01) and a significantly greater BG levels during OGTT at minute 30 (149.97 ± 8.53 vs. 110.53 ± 12.60 mg/dl; p=0.02), 60 (149.80 ± 9.33 vs. 104.99 ± 17.21 mg/dl; p=0.03) and 90 (116.48 ± 6.62 vs. 71.71 ± 10.11 mg/dl; p< 0.01) compared to B. All individuals with a monophasic OGTT response had a FH whereas most individuals with biphasic OGTT response (7/10) did not.

Conclusion: Although having similar fasting BG, body composition, substrate utilization, and aerobic fitness, a monophasic compared to biphasic, OGTT reflects glucose intolerance and risk for developing T2D.

Disclosure

J. Jenkins: None. C. Meza: None. M. Amador: None. A.J. McAinch: None. S. Bajpeyi: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.